The EU Ecosystem in Nanomedicine
Patrick Boisseau
15 July, 2018
Topline Results Alirocumab in Patients After Acute Coronary Syndrome
Gregory G. Schwar...
26 June, 2018
Pre-Transplant Immunogenetic and Immunological Assessment for Hematopietic Stem Cell Transplantation
Uma Kanga PhD
25 June, 2018
Phase 1 Trial of Single and Multiple Dose Subcutaneously Administered Factor IX Variant ISU304/CB 2679d: Pharmacokinetics, Activity and Safety
Chur Woo You MD P...
07 June, 2018
Cancer Research Current Trends & Future Directions
25 May, 2018
The Biotech Specialised In Diseases of Aging
Stanislas Veillet...
21 May, 2018
Senhwa Biosciences, Inc
Benny Hu, Tai-Sen...
19 May, 2018
Real World Evidence: Sanofi's Strategy
Ameet Nathwani MD...
17 May, 2018
Developing First-In-Class Cardiovascular Drugs
Lionel Segard, Je...
09 May, 2018
Phase 1/2, Randomized, Placebo Controlled and Open Label Extension Studies of Givosiran, an Investigational RNA Interference (RNAi) Therapeutic, in Patients with Acute Intermittent Porphyria
Eliane Sardh MD P...
06 May, 2018
Precision Nanomedicine for People An (almost) invisible revolution
Johanna K Scheper...
03 May, 2018
Sea Food Security, Thanks to Algae
Martin C. Th. Sch...
25 April, 2018
Trends in Neuro Device Investing
Bill Sideris, Chr...
20 April, 2018
Ticagrelor with Aspirin on Platelet Reactivity in Acute Non-disabling Cerebrovascular Events (PRINCE) Trial
Yilong Wang MD Ph...
19 April, 2018
Heat Biologics
Heat Biologics, I...
09 April, 2018
Novartis Pharmaceuticals: Driving Growth
Paul Hudson
06 April, 2018
Global integrated biotech developing marine-inspired and novel MoA oncology drugs
05 April, 2018
Advancing Breakthrough Products  for Blood Clots and Blood Cancers to the Market
Portola Pharmaceu...
04 April, 2018
Regulation and Innovation in Japan
Takao Yamori PhD
02 April, 2018
Fennec Pharma

Fennec Pharma

During the course of this presentation we will mak

Khalis Islam PhD,...
29 March, 2018